Pranidipine, a novel calcium antagonist, once daily, for the treatment of hypertension : A multicenter, double-blind, placebo-controlled dose-finding studyROSENTHAL, J; HITTEL, N; STUMPE, K. O et al.Cardiovascular drugs and therapy. 1996, Vol 10, Num 1, pp 59-66, issn 0920-3206Article

Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infectionsNENOFF, P; HAUSTEIN, U.-F; HITTEL, N et al.Chemotherapy (Basel). 2004, Vol 50, Num 4, pp 196-201, issn 0009-3157, 6 p.Article

Down-regulation of interferon-γ parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease : a 12-month follow-up studyMURATOV, V; LUNDAHL, J; ULFGREN, A. K et al.International journal of colorectal disease (Print). 2006, Vol 21, Num 6, pp 493-504, issn 0179-1958, 12 p.Article

Topical quinolone nadifloxacin (OPC-7251) in bacterial skin disease : clinical evaluation in a multicenter open trial and in vitro antimicrobiological susceptibility testingHAUSTEIN, U.-F; NENOFF, P; HITTEL, N et al.Journal of dermatological treatment. 1997, Vol 8, Num 2, pp 87-92, issn 0954-6634Article

Prolonged hypotensive effect of OPC-13340 : a new, once-daily calcium channel blocking drugBROADHURST, P; BRIGDEN, G; HITTEL, N et al.European heart journal. 1991, Vol 12, Num 3, pp 434-438, issn 0195-668X, 5 p.Article